Evidence map›Paper›PMID 30403813›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2020

Impaired urinary concentration ability is a sensitive predictor of renal disease progression in Joubert syndrome.

Sara Nuovo, Laura Fuiano, Alessia Micalizzi, Roberta Battini, Enrico Bertini, Renato Borgatti, Gianluca Caridi, Stefano D'Arrigo, Elisa Fazzi, Rita Fischetto and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. A Novel Pathogenic Splicing Mutation ofPharmacogenomics and personalized medicine · 2025
    Article
  2. Review
  3. Nephronophthisis: a pathological and genetic perspective.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  4. Article
  5. Observational
  6. Article
  7. NovelOpen life sciences · 2023
    Article
  8. Article
  9. Genotype-phenotype correlates in Joubert syndrome: A review.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  10. Article
  11. Mouse genetics reveals Barttin as a genetic modifier of Joubert syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Healthcare recommendations for Joubert syndrome.American journal of medical genetics. Part A · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 1 country.

Sara NuovoNeurogenetics Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Laura FuianoDepartment of Nephrology and Urology, Unit of Nephrology and Dialysis, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Alessia MicalizziNeurogenetics Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Roberta BattiniDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Enrico BertiniLaboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Renato BorgattiNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
Gianluca CaridiLaboratory of Molecular Nephrology, Istituto Giannina Gaslini IRCCS, Genoa, Italy.
Stefano D'ArrigoDevelopmental Neurology Division, Foundation IRCCS Neurological Institute Carlo Besta, Milan, Italy.
Elisa FazziChild and Adolescent Neurology and Psychiatry Unit, Children Hospital, ASST Spedali Civili of Brescia, Brescia, Italy.
Rita FischettoClinical Genetics Unit, Department of Paediatric Medicine, Giovanni XXIII Children's Hospital, Bari, Italy.
Gian Marco GhiggeriLaboratory of Molecular Nephrology, Istituto Giannina Gaslini IRCCS, Genoa, Italy.
Lucio GiordanoChild and Adolescent Neurology and Psychiatry Unit, Children Hospital, ASST Spedali Civili of Brescia, Brescia, Italy.
Vincenzo LeuzziDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Romina RomanielloNeuropsychiatry and Neurorehabilitation Unit, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
Sabrina SignoriniUnit of Child Neurology and Psychiatry, IRCCS C. Mondino Foundation, Pavia, Italy.
Gilda StringiniDepartment of Nephrology and Urology, Unit of Nephrology and Dialysis, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Ginevra ZanniLaboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Marta RomaniMolecular Genetics Laboratory, Eurofins GENOMA Group, Rome, Italy.
Enza Maria ValenteNeurogenetics Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Francesco EmmaDepartment of Nephrology and Urology, Unit of Nephrology and Dialysis, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Bambino Gesù Children's Hospital · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITIRCCS Eugenio Medea · ITIstituto Giannina Gaslini · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITFondazione Santa Lucia · ITOspedale Pediatrico Giovanni XXIII · ITSapienza University of Rome · ITUniversity of Pavia · ITUniversity of Pisa · ITUniversity of Salerno · IT

Funding

European Research Council 260888
6 · The paper itself

Abstract

backgroundJoubert syndrome (JS) is an inherited ciliopathy characterized by a complex midbrain-hindbrain malformation and multiorgan involvement. Renal disease, mainly juvenile nephronophthisis (NPH), was reported in 25-30% patients although only ∼18% had a confirmed diagnosis of chronic kidney disease (CKD). NPH often remains asymptomatic for many years, resulting in delayed diagnosis. The aim of the study was to identify a biomarker able to quantify the risk of progressive CKD in young children with JS.

methodsRenal features were investigated in 93 Italian patients, including biochemical tests, ultrasound and 1-deamino-8D-arginine vasopressin test in children with reduced basal urine osmolality. A subset of patients was followed-up over time.

resultsAt last examination, 27 of 93 subjects (29%) presented with CKD, ranging from isolated urinary concentration defect (UCD) to end-stage renal disease. Both normal and pathological urine osmolality levels remained stable over time, even when obtained at very early ages. Follow-up data showed that the probability of developing CKD can be modelled as a function of the urine osmolality value, exceeding 75% for levels <600 mOsm/kg H2O, and significantly increased in patients with an early diagnosis of isolated UCD.

conclusionsWe conclude that the frequency of CKD in JS increases with age and is higher than previously reported. Urine osmolality represents an early sensitive quantitative biomarker of the risk of CKD progression.

Indexed as

Abnormalities, MultipleAdolescentAdultBiomarkersCerebellumChildChild, PreschoolDisease ProgressionEye AbnormalitiesFemaleHumansInfantInfant, NewbornKidney Diseases, CysticMaleOsmolar ConcentrationBiomarkers1-deamino-8D-arginine vasopressin testearly diagnosisJoubert syndromenephronophthisisurine osmolality

Identifiers

PMID30403813
PMCPMC7417010
OpenAlexW2905586728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.